| Primary |
| Hypertension |
28.9% |
| Drug Use For Unknown Indication |
18.4% |
| Product Used For Unknown Indication |
18.4% |
| Cardiac Disorder |
7.9% |
| Aplastic Anaemia |
5.3% |
| Atrial Fibrillation |
5.3% |
| Portal Hypertension |
5.3% |
| Renal Cell Carcinoma |
5.3% |
| Blood Glucose Increased |
2.6% |
| Hypertensive Crisis |
2.6% |
|
| Maternal Exposure During Pregnancy |
14.3% |
| Premature Labour |
11.9% |
| Foetal Exposure During Pregnancy |
7.1% |
| Lupus-like Syndrome |
7.1% |
| Medication Error |
7.1% |
| Blood Pressure Inadequately Controlled |
4.8% |
| Completed Suicide |
4.8% |
| Low Birth Weight Baby |
4.8% |
| Nausea |
4.8% |
| Premature Baby |
4.8% |
| Premature Delivery |
4.8% |
| Tremor |
4.8% |
| Acute Febrile Neutrophilic Dermatosis |
2.4% |
| Angioedema |
2.4% |
| Drug Hypersensitivity |
2.4% |
| Flushing |
2.4% |
| Interstitial Lung Disease |
2.4% |
| Lupus Pneumonitis |
2.4% |
| Muscle Spasms |
2.4% |
| Normal Newborn |
2.4% |
|
| Secondary |
| Hypertension |
21.2% |
| Maternal Exposure Timing Unspecified |
20.3% |
| Type 2 Diabetes Mellitus |
20.3% |
| Product Used For Unknown Indication |
15.3% |
| Aplastic Anaemia |
5.1% |
| Cardiac Failure |
3.4% |
| Essential Hypertension |
2.5% |
| Lupus Nephritis |
1.7% |
| Renal Cell Carcinoma |
1.7% |
| Systemic Lupus Erythematosus |
1.7% |
| Angina Pectoris |
0.8% |
| Anxiety Disorder |
0.8% |
| Bipolar Disorder |
0.8% |
| Constipation |
0.8% |
| Gout |
0.8% |
| Haemolytic Uraemic Syndrome |
0.8% |
| Lung Adenocarcinoma |
0.8% |
| Oesophageal Disorder |
0.8% |
|
| Renal Failure Acute |
15.0% |
| Maternal Exposure During Pregnancy |
12.5% |
| Medication Error |
7.5% |
| Renal Aplasia |
7.5% |
| Foetal Exposure During Pregnancy |
5.0% |
| Neonatal Respiratory Distress Syndrome |
5.0% |
| Pain |
5.0% |
| Premature Baby |
5.0% |
| Productive Cough |
5.0% |
| Shock |
5.0% |
| Syncope |
5.0% |
| Abscess |
2.5% |
| Anxiety |
2.5% |
| Blood Pressure Systolic Increased |
2.5% |
| Completed Suicide |
2.5% |
| Drug Hypersensitivity |
2.5% |
| Granulomatous Liver Disease |
2.5% |
| Libido Decreased |
2.5% |
| Low Birth Weight Baby |
2.5% |
| Renal Hypoplasia |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
39.9% |
| Drug Use For Unknown Indication |
20.2% |
| Hypertension |
11.9% |
| Prophylaxis |
3.6% |
| Renal Failure Chronic |
3.1% |
| Cardiac Failure |
2.8% |
| Pain |
2.6% |
| Renal Transplant |
2.3% |
| Diabetes Mellitus |
2.0% |
| Atrial Fibrillation |
1.7% |
| Cerebrovascular Accident |
1.6% |
| Dialysis |
1.2% |
| Hepatitis C |
1.2% |
| Anaemia |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Haemodialysis |
0.9% |
| Hepatic Neoplasm Malignant |
0.9% |
| Diuretic Therapy |
0.8% |
| Systemic Lupus Erythematosus |
0.8% |
| Type 2 Diabetes Mellitus |
0.8% |
|
| Vomiting |
16.5% |
| Therapeutic Response Decreased |
12.2% |
| Premature Baby |
5.2% |
| Renal Failure Acute |
5.2% |
| Unresponsive To Stimuli |
5.2% |
| Ischaemic Stroke |
4.3% |
| Pregnancy |
4.3% |
| Pyelonephritis |
4.3% |
| Pyrexia |
4.3% |
| Syncope |
4.3% |
| Cerebral Ischaemia |
3.5% |
| Chest Pain |
3.5% |
| Hypertension |
3.5% |
| Hypoglycaemia |
3.5% |
| Parvovirus B19 Serology Positive |
3.5% |
| Pneumonia |
3.5% |
| Rash |
3.5% |
| Urinary Tract Infection |
3.5% |
| Weight Decreased |
3.5% |
| Cardiac Failure Congestive |
2.6% |
|
